Our comprehensive oncology product basket comprises of fifty products. All our oncology products catering to cancer treatment are produced with strict adherence to ethical standards and global norms of W.H.O. GMP guidelines.
To extend physical and mental support to people grappling with the challenges of cancer, we have initiated several cancer care programs. The programs are intended to keep cancer patients and their families motivated during the course of their treatment by the anti cancer medicines. The concept is to convince them that in this strive against cancer, they are not alone.
The COPP is the legal document that declares a certain manufacturing company is legally allowed to sell their pharmaceutical or an oncology product in the country they are producing. When registering a pharmaceutical product overseas, the government body in charge of approving the application will usually require a COPP to ensure that the product or chemotherapy medicines are being sold as a commercial finished product in the country that is producing it.
Admac Lifesciences has all its products and oncology medicines complying with the COPP standards- which includes lyophilised injections, liquid injections, tablets and capsules.
ADMAC has state of the art manufacturing facilities for the development of anticancer medicine. All manufacturing facilities are designed as per GMP guidelines.
Being one of the fastest growing pharmaceutical companies for the cancer vaccine in India, we have always invested in building modern manufacturing facilities to increase our production capacities to meet the growing demand of our products.
Our anti cancer medicine manufacturing facilities are approved by WHO-GMP as well as the various regulatory bodies of the respective countries we operate in.
All facilities are equipped with advanced automation systems. HVAC system is designed with Variable Frequency Drive (VFD), Programmable Logic Controller (PLC) with automatic data recording monitors process control like air distribution, temperature, humidity, auto cleaning process, security by interlocking, auto loading, unloading and Cleaning-In-Place(CIP).
Our facilities have segregated de-humidified areas for manufacturing moisture-sensitive oncology products. Stainless steel panels are used for in-sterile facility core areas. The maintenance and servicing are done from the top of a false ceiling without entering the manufacturing areas.
Admac’s state-of-the-art manufacturing facilities are designed as per USFDA guidelines. The facilities are constructed and designed with maximum consideration given to current Good Manufacturing Practices (cGMP). Admac Lifesciences foothold has also spread to international soil. Our aim is to ensure better access of the affordable chemotherapy medicine. Thus, we have branched out to global markets so that we reach as many people as possible. Currently, we have a hold in 10 countries across the globe with a wide range of products and anticancer medicines.
For newly diagnosed CD33-positive AML (acute myeloid leukemia), the FDA (Food and Drug Administration) extended the indication of gemtuzumab ozogamicin (MYLOTARG, Wyeth Pharmaceuticals LLC) on 16 June 2020 …
For adult patients with metastatic SCLC (small cell lung cancer) with disease progression on or after platinum-based chemotherapy, lurbinectedin (ZEPZELCA, Pharma Mar S.A.) received FDA (Food and Drug …
At ESMO World Congress on Gastrointestinal Cancer 2020 Virtual (1-4 July), the findings of additional analysis of the POLO trial in Chicago depicted that in patients with a …
At Admac we aim at providing innovative World-Standard medicines for all, at affordable prices. Admac is fully committed towards WHO standards; quality & growth, latest technology & R & D with sheer hard work and dedicated team work.